These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18240276)

  • 1. Discovery of a stable molecular complex of an API with HCl: a long journey to a conventional salt.
    Peresypkin A; Variankaval N; Ferlita R; Wenslow R; Smitrovich J; Thompson K; Murry J; Crocker L; Mathre D; Wang J; Harmon P; Ellison M; Song S; Makarov A; Helmy R
    J Pharm Sci; 2008 Sep; 97(9):3721-6. PubMed ID: 18240276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time endpoint monitoring and determination for a pharmaceutical salt formation process with in-line FT-IR spectroscopy.
    Lin Z; Zhou L; Mahajan A; Song S; Wang T; Ge Z; Ellison D
    J Pharm Biomed Anal; 2006 Apr; 41(1):99-104. PubMed ID: 16321495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical interactions between an active pharmaceutical ingredient and its counterion in a tromethamine salt under forced degradation conditions.
    Loeser E; Sutton P; Skorodinsky A; Lin M; Yowell G
    Drug Dev Ind Pharm; 2012 Mar; 38(3):357-64. PubMed ID: 22088139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of stoichiometric and nonstoichiometric hydrate forms of paroxetine HCl: reversible changes in crystal dimensions as a function of water absorption.
    Pina MF; Pinto JF; Sousa JJ; Fábián L; Zhao M; Craig DQ
    Mol Pharm; 2012 Dec; 9(12):3515-25. PubMed ID: 23051151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical aspects of salt and cocrystal forms of APIs and characterization challenges.
    Cerreia Vioglio P; Chierotti MR; Gobetto R
    Adv Drug Deliv Rev; 2017 Aug; 117():86-110. PubMed ID: 28687273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of crystalline forms in active pharmaceutical ingredient and tablets by X-ray powder diffraction.
    Cooper VB; Pearce GE; Petts CR
    J Pharm Pharmacol; 2003 Sep; 55(9):1323-9. PubMed ID: 14604477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of a new mebendazole salt: mebendazole hydrochloride.
    Brusau EV; Camí GE; Narda GE; Cuffini S; Ayala AP; Ellena J
    J Pharm Sci; 2008 Jan; 97(1):542-52. PubMed ID: 17854049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal forms of the hydrogen oxalate salt of o-desmethylvenlafaxine.
    Dichiarante E; Curzi M; Giaffreda SL; Grepioni F; Maini L; Braga D
    J Pharm Pharmacol; 2015 Jun; 67(6):823-9. PubMed ID: 25644936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chloride ion on dissolution of different salt forms of haloperidol, a model basic drug.
    Li S; Doyle P; Metz S; Royce AE; Serajuddin AT
    J Pharm Sci; 2005 Oct; 94(10):2224-31. PubMed ID: 16136556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structures and physicochemical properties of vortioxetine salts.
    Zhou X; Hu X; Wu S; Ye J; Sun M; Gu J; Zhu J; Zhang Z
    Acta Crystallogr B Struct Sci Cryst Eng Mater; 2016 Oct; 72(Pt 5):723-732. PubMed ID: 27698313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
    Morissette SL; Almarsson O; Peterson ML; Remenar JF; Read MJ; Lemmo AV; Ellis S; Cima MJ; Gardner CR
    Adv Drug Deliv Rev; 2004 Feb; 56(3):275-300. PubMed ID: 14962582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inversion twinning in a second polymorph of the hydrochloride salt of the recreational drug ethylone.
    Cameron TS; Grossert JS; Maheux CR; Alarcon IQ; Copeland CR; Linden A
    Acta Crystallogr C Struct Chem; 2015 Apr; 71(Pt 4):266-70. PubMed ID: 25836283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tris(hydroxymethyl) aminomethane salt of ramipril: synthesis, structural characterization from X-ray powder diffraction and stability studies.
    Bhattacharya A; Chattopadhyay B; Chakraborty S; Roy BN; Singh GP; Godbole HM; Rananaware UB; Mukherjee AK
    J Pharm Biomed Anal; 2012 Nov; 70():280-7. PubMed ID: 22877875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulating weakly basic HCl salts: relative ability of common excipients to induce disproportionation and the unique deleterious effects of magnesium stearate.
    John CT; Xu W; Lupton LK; Harmon PA
    Pharm Res; 2013 Jun; 30(6):1628-41. PubMed ID: 23512680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of in situ near infrared imaging and Raman mapping to study the disproportionation of a drug HCl salt during dissolution.
    Wray PS; Sinclair WE; Jones JW; Clarke GS; Both D
    Int J Pharm; 2015 Sep; 493(1-2):198-207. PubMed ID: 26200745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The salt-cocrystal continuum: the influence of crystal structure on ionization state.
    Childs SL; Stahly GP; Park A
    Mol Pharm; 2007; 4(3):323-38. PubMed ID: 17461597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pepsin on maintaining the supersaturation of the HCl salt of a weakly basic drug: a case study.
    Pinnamaneni S; Rinaldi FA; Jayawickrama DA; Li J; Dali MV
    Pharm Dev Technol; 2016; 21(3):311-20. PubMed ID: 25708152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of salt screening methodologies.
    Fernández Casares A; Nap WM; Ten Figás G; Huizenga P; Groot R; Hoffmann M
    J Pharm Pharmacol; 2015 Jun; 67(6):812-22. PubMed ID: 25683791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Selection of a Pharmaceutical Salt-The Effect of the Acidity of the Counterion on Its Solubility and Potential Biopharmaceutical Performance.
    He Y; Orton E; Yang D
    J Pharm Sci; 2018 Jan; 107(1):419-425. PubMed ID: 29107790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.